Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

scPharmaceuticals Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-16Dec-31-15
Revenues11.98.3
            Revenue growth43.4% 
Cost of goods sold17.910.8
Gross profit-6.1-2.6
            Gross margin-51.1%-31.2%
General and administrative6.12.6
EBIT-17.9-10.8
            EBIT margin-151.1%-131.2%
Pre-tax income-24.4-10.5
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-24.4-10.5
            Net margin-205.6%-127.2%
 
Diluted EPS($25.01)($13.78)
Shares outstanding (diluted)1.00.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2017 | Contact Us | Terms of Use | Privacy